CTRI/2022/04/041728尚未招募2 期
Comparision of saftey and efficacy of Mometasone 0.1% cream, Calcipotriol 0.005% ointment and topical Tacrolimus 0.1% ointment; in patients with localized alopecia areata, a triple arm randomized control trial
SOA University0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Patients >18 years of age.
- •2)All patients with localized alopecia ( < 5 patches) on the scalp
排除标准
- •1)Early age of onset of alopecia areata
- •2)Nail changes
- •3)Duration > 1 year
- •4)Family history of Alopecia Areata
- •5)Patterns-ophiasis, sisaipho, reticular
- •6)Active infection at lesional site.
- •7)Associated autoimmune disease.
- •8)Pregnancy
- •9) Received any prior treatment within a month
- •10) Hormonal association
- •11) Endocrine abnormality
研究者
相似试验
进行中(未招募)
不适用
The effectiveness of Mometasone Furoate plus Isotonic Nasal Saline in the Elderly with RhinitisJ31.0Chronic rhinitisRBR-498bnqPrograma de Pós Graduação em Ciências Médicas da Universidade Federal Fluminense
Enrolling By Invitation
2 期
A Study of Therapeutic Equivalence of mometasone cream and Elomet cream in eczemaPreventive or screening interventionsMometasone cream, elomet cream, eczemaTCTR20220210004Zuellig Pharma80
Enrolling By Invitation
2 期
A study of therapeutic equivalence of mometasone lotion and Elomet lotion in seborrheic dermatitis of scalpSeborrheic dermatitis of scalpSeborrheic dermatitis of scalp, mometasone lotion, Elomet lotionTCTR20220215001HOE Pharmaceuticals Sdn. Bhd.100
招募中
3 期
The effect of topical Mometasone 0.1% and topical Hydrocortisone 1% in the prevention of acute radiation dermatitis of breastIRCT20180222038825N1Esfahan University of Medical Sciences120
已完成
不适用
STUDY ON THE EFFICACY AND SAFETY OF MOMETHASONE FUROATE IN DRY POWDER INHALER IN THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE-J449 Chronic obstructive pulmonary disease, unspecifiedChronic obstructive pulmonary disease, unspecifiedJ449PER-029-01SCHERING PLOUGH RESEARCH INSTITUTE,
